NBGTX
Price
$33.63
Change
-$0.08 (-0.24%)
Updated
Dec 3 closing price
Net Assets
2.67B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

NBGTX vs VIGRX

Header iconNBGTX vs VIGRX Comparison
Open Charts NBGTX vs VIGRXBanner chart's image
Neuberger Berman Large Cap Growth Tr
Price$33.63
Change-$0.08 (-0.24%)
VolumeN/A
Net Assets2.67B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
NBGTX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
NBGTX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBGTX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. NBGTX (2.67B). VIGRX pays higher dividends than NBGTX: VIGRX (0.30) vs NBGTX (0.00). NBGTX was incepted earlier than VIGRX: NBGTX (32 years) vs VIGRX (33 years). NBGTX (1.01) is less costly to investors than VIGRX (0.17). NBGTX is a more actively managed with annual turnover of: 30.00 vs. VIGRX (11.00). NBGTX has a lower initial minimum investment than VIGRX: NBGTX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. NBGTX (8.04). VIGRX return over 5 years is better than : 99.11 vs. NBGTX (34.86).
NBGTXVIGRXNBGTX / VIGRX
Total Expense Ratio1.010.17594%
Annual Report Gross Expense Ratio1.010.17594%
Fund Existence32 years33 years-
Gain YTD15.04819.76476%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.67B357B1%
Annual Yield % from dividends0.000.300%
Returns for 1 year8.0418.4943%
Returns for 3 years54.98110.8250%
Returns for 5 years34.8699.1135%
Returns for 10 years61.53349.1318%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT